Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch... see more

TSX:SVA - Post Discussion

Sernova Corp > And today we're mentioned in the Globe and Mail
View:
Post by rixpix on Jan 18, 2022 8:36am

And today we're mentioned in the Globe and Mail

The Globe's David Leeder writes that Ms. Stellick set a share target of $3. GL.
Comment by Stockfshr on Jan 18, 2022 8:49am
Yes. Love that the Globe reused the word "blockbuster" from Chelsea's report. "Ms. Stellick thinks Sernova possesses "blockbuster potential to establish a new standard of care for diabetes treatment and apply its platform to other chronic diseases using several complementary technologies."
Comment by BioTeck on Jan 18, 2022 9:15am
Blockbuster is synonymous with bankrupt haha. I can still see that ugly blue and yellow logo.
Comment by Stockfshr on Jan 18, 2022 11:15am
How about the word "disruptive", BioTeck? I love that word too! Blockbuster + disruptive = profits!
Comment by BioTeck on Jan 18, 2022 4:09pm
Another disruptive day. With the lack of a blockbuster deal we continue to trickle back to 1.20. If management is sitting on any news. Now is the time to release it. Actually let's wait for another conference, that seems to always work.
Comment by Stockfshr on Jan 18, 2022 4:25pm
Don't worry. We will definitely rally from these or lower levels! :)
Comment by Ekenbullets on Jan 19, 2022 7:29am
Didnt Charly say deal in september? Perhaps it was 2022...
Comment by Charly50 on Jan 19, 2022 8:05am
View PT's original email again......
Comment by Metalsguy1 on Jan 19, 2022 1:04pm
Frauulein smokes a lot of crack. I would not rely on her predictions.
Comment by Charly50 on Jan 18, 2022 9:37am
good this form of media coverage!!! The right way....
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities